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 The rapid emergence of resistant bacteria is occurring worldwide. Antibiotic resistance is a serious 
problem for human beings because pathogenic microorganisms that acquire such resistance void antibiotic 
treatments. Bacterial antibiotic resistance mechanisms include efflux, reduced influx, modification and 
degradation of the drug, as well as mutation, modification or overexpression of the target. However, our 
knowledge as to how bacteria acquire antibiotic resistance is still fragmented, especially for ribosome-targeting 
drugs. Salmonella is a leading cause of foodborne salmonellosis in the world. The number of antibiotic 
resistant isolates identified in humans is steadily increasing, suggesting that the spread of antibiotic resistant 
strains is a major threat to public health. Salmonella is commonly identified in a wide range of animal hosts, 
food sources, and environments, but our knowledge as to how Salmonella resistance to antibiotics is still 
fragmented in this ecologically complex serovar. Therefore, the aim of this study was to support for finding 
novel mechanisms that render bacteria resistant to the ribosome targeting antibiotics, we screen for antibiotic 
resistant 16S and 23S ribosomal RNAs (rRNAs) in multidrug resistant Salmonella serovars isolated from raw 
retail meats isolated from Hanoi, Vietnam. Bioinformatic analysis identified 193 unknown novel mutations (64 
mutations in 16S rRNA and 129 mutations in 23S rRNA genes). These mutations might play a role in 
streptomycin resistant in Salmonella serovars. These results suggest that uncharacterized antibiotic resistance 
mutations still exist, even for traditional antibiotics. This study is only a preliminary kind, further validation 
before they are applied in Salmonella or other closely related species are required. 
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INTRODUCTION 
 Aminoglycosides are used in treating a wide 
range of infections caused by gram-negative bacteria 
and has been classified by the World Health 
Organization as critically important antimicrobial 
drugs. They inhibit bacterial protein synthesis by 
binding to the 16S ribosomal subunit, leads to 
bacteria death. Resistance to these antimicrobial 
agents usually results from the production of 
aminoglycoside-modifying enzymes, reduced 
intracellular antibiotics accumulation, or mutation of 
ribosomal proteins or rRNA. An additional 
mechanism, methylation of the aminoacyl site of 16S 
rRNA, confers high level resistance to clinically 
crucial aminoglycosides such as streptomycin and 
gentamicin (Bonomo, Szabo, 2006; Fair, Tor, 2014; 
Katie et al., 2010; Kohanski et al., 2010). 
Exogenously acquired 16S rRNA methyltransferase 
(16S-RMTase) genes responsible for a really high 
level of resistance to various aminoglycosides have 
been widely distributed among Enterobacteriaceae 
including Salmonella serovars. This genetic 
apparatus may thus contribute to the rapid worldwide 
dissemination of the resistance mechanism among 
pathogenic bacteria. The worldwide dissemination of 
16S-RMTases is becoming a global concern and this 
implies the necessity to continue investigations on 
the trend of 16S-RMTases to restrict their further 
worldwide dissemination (Wachino, Arakawa, 
2012). 
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 The ribosome is functionally critical sites exist 
mainly on RNAs, many antibiotic target sites exist 
on rRNAs, as several resistant point mutations 
(Moazed, Noller, 1987; Yassin et al., 2005). This is 
because ribosomes play a crucial role in protein 
biosynthesis, translating messenger RNA encoded 
genetic information into proteins, which consists of 
sequential multistep reactions such as initiation, 
elongation, termination, and recycling. Owing to 
these extremely elaborate reaction dynamics, there 
are different sorts of inhibitors targeting each step of 
the translation process (Wilson, 2013). Acquisition 
of mutations in target sites of the antimicrobial 
mechanism is often observed for ribosome targeting 
drugs such as aminoglycosides (e.g., streptomycin, 
gentamycin), tetracycline, chloramphenicol, 
macrolides, lincomycins, streptogramin A, and 
oxazolidinones; the former three are known to target 
the 30S subunit that contains the 16S rRNA as its 
main component, whereas the others are known to 
attack the 50S subunit that contains the 23S rRNA as 
its main component (Wilson, 2006). 
 Our knowledge as to how bacteria acquire 
antibiotic resistance is still fragmented, especially for 
the ribosome targeting drugs. Therefore, tremendous 
effort is being made to identify the mechanisms and 
mutations that lead to bacterial resistance to 
antibiotics. There are many unfound and 
uncharacterized antibiotic resistance point mutations 
in rRNA genes. Understanding this can help ensure 
we can effectively treat bacterial infections such as 
Salmonella serovars. Researchers have long tried to 
list as many resistant point mutations in rRNAs as 
possible (Miyazaki, Kitahara, 2018). There is limited 
information about point mutations in 16S rRNA and 
23S rRNA genes in Salmonella isolated from retail 
meats in Vietnam. Thus, this study aims to detect 
point mutations in 16S rRNA and 23S rRNA genes, 
which is one of keys to prevent the spread of 
multidrug-resistant Salmonella serovars. 
MATERIALS AND METHODS 
Collection and preparation of samples 
 A total of 25 Salmonella serovars were 
serotyped and received from laboratory in Institute 
of Genome Research, Vietnam Academy of Science 
and Technology, including 2 S. warragul, 1 S. 
london, 4 S. derby, 2 S. indiana, 1 S. meleagridis, 1 
S. give, 2 S. rissen, 11 S. typhimurium and 1 S. 
assine. The originated strains from pork, beef and 
chicken meat at retail markets in Hanoi, Vietnam. 
Antibiotic susceptibility tests 
 The antimicrobial susceptibility test was 
performed according to the Clinical and Laboratory 
Standards Institute (CLSI-2015) and used the disk 
diffusion method as Kirby-Bauer’s description. Drug 
susceptibility was tested on the Muller Hinton agar 
plates. Cultures were grown at 37oC for 18-24 h in 
Brain Heart Broth Infusion (Biolife-Italia) and 
prepared on Mueller-Hinton agar. The antibiotic 
disks were placed aseptically on it and plates were 
incubated at 37oC for 16-18 h. 
 The eight tested antimicrobials were often used 
in husbandry and treatment of animal farms as well 
as human diseases in Vietnam such as ampicillin 
(AMP) 10 µg, ceftazidime (CAZ) 30 µg, gentamicin 
(GEN) 10 µg, streptomycin (STR) 10 µg, 
ciprofloxacin (CIP) 5 µg, chloramphenicol (CHL) 30 
µg, tetracycline (TET) 30 µg, and 
trimethoprim/sulfamethoxazole (SXT) 1.25/23.75 µg 
(BD Diagnostics). 
RNA sequencing and virulence gene detection 
 Total RNA was extracted from Salmonella spp. 
according to the manufacturer’s instructions (TRIzol 
Reagent, Life Technologies Inc.). RNA was 
concentrated and purified with an RNA MinElute kit 
(Qiagen). mRNA-seq libraries were produced from 
1 µg of genomic RNA libraries, following the 
TruSeq Nano DNA Sample Preparation Guide, Part 
# 15041110 Rev. Library preparations were 
sequenced on a HiSeq4000 (Illumina) platform 
(Next Generation Sequencing Div. MACROGEN, 
Inc., Daejeon, Korea) using TruSeq Nano DNA Kit. 
The trimmomatic program was used to remove 
adapter sequences. The trimmomatic program was 
used to remove adapter sequences. All subsequent 
analyses were based on high quality, clean data. 
Transcriptome de novo assembly using automated 
parameters in Geneious R11 software (Kearse et al., 
2012). The 16S rRNA gene mutations were analyzed 
using ResFinder (Center for Genomic Epidemiology) 
(Zankari et al., 2012). 
RESULTS 
Antibiotic resistance of Salmonella isolates 
 Twenty-five Salmonella spp. were tested for 
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antibiotic resistance against 8 antibiotics. All 
strains were susceptible to CAZ, and 52% of the 
isolates were resistant to at least one antibiotic 
(data not showed). Total 9 Salmonella isolates 
were shown the multi-antimicrobial resistance, 
including one S. meleagridis, one S. derby, one S. 
give, three S. typhimurium, one S. warragul, one 
S. indiana, and one S. rissen). In addition, S. 
indiana isolate from chicken showed resistance to 
8 antibiotics (Table 1). 
 
In silico 16S rRNA and 23S rRNA gene mutation 
analysis 
 Six out of nine multidrug resistance samples 
were selected for mRNA sequencing, including S. 
indiana (Sal 4), S. derby (Sal 6), S. give (Sal 7), S. 
typhimurium S360 (Sal 8), S. typhimurium S384 (Sal 
11), and S. typhimurium S181 (Sal 12). A total of 
193 point mutations were identified (64 point 
mutations in 16S rRNA and 129 point mutations in 
23S rRNA). A listing over the mutations among 
isolates was presented in Table 2. 
Table 1. Susceptibility results of multidrug-resistant Salmonella isolates. 
Salmonella serovar 
Antibiotics 
AMP CAZ GEN STR CIP CHL TET SXT 
Indiana R S R R R R R R 
Rissen S S S R S R R R 
Warragul S S S S S R R R 
Typhimurium S384 R S R R S R R R 
Give R S S R S R R R 
Meleagridis R S S R S R R R 
Derby R S S R S S R S 
Typhimurium S181 R S S R S S R S 
Typhimurium S360 R S S R S R R R 
Abbreviations: R (resistant); S (sensitive) 
 
Table 2. Mutations in 16S rRNA and 23S rRNA genes among isolates. 
 
Sal 4 Sal 6 Sal 7 Sal 8 Sal 11 Sal 12 
16S_rrsD r.45A>G 16S_rrsD r.54A>G 16S_rrsD r.54A>G 16S_rrsD r.54A>G 16S_rrsD r.45A>G 16S_rrsD r.45A>G 
16S_rrsD r.54A>G 16S_rrsD r.642G>T 16S_rrsD r.248C>A 16S_rrsD r.636T>A 16S_rrsD r.54A>G 16S_rrsD r.54A>G 
16S_rrsD r.248C>T 16S_rrsD r.744T>C 16S_rrsD r.642G>T 16S_rrsD r.645G>A 16S_rrsD r.702T>C 16S_rrsD r.702T>C 
16S_rrsD r.260A>G 16S_rrsD r.756G>C 16S_rrsD r.726T>C 16S_rrsD r.648C>T 16S_rrsD r.756G>C 16S_rrsD r.756G>C 
16S_rrsD r.891C>T 
16S_rrsD 
r.1164T>C 16S_rrsD r.756G>C 16S_rrsD r.891C>T 16S_rrsD r.1047C>T 16S_rrsD r.1047C>T 
16S_rrsD r.933G>A 
16S_rrsD 
r.1272G>C 16S_rrsD r.900G>T 
16S_rrsD 




r.1441T>C 16S_rrsD r.921G>A 
16S_rrsD 




r.1650A>G 16S_rrsD r.1095T>G 
16S_rrsD 




r.1749G>A 16S_rrsD r.1161G>A 
16S_rrsD 




r.1836C>T 16S_rrsD r.1218A>G 
16S_rrsD 




r.1860T>C 16S_rrsD r.1254C>T 
16S_rrsD 
r.1287T>C 16S_rrsD r.1344T>C 16S_rrsD r.1344T>C 
16S_rrsD 16S_rrsD 16S_rrsD r.1281T>C 16S_rrsD 16S_rrsD r.1356G>A 16S_rrsD r.1356G>A 
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r.1866G>A 16S_rrsD r.1293T>C 
16S_rrsD 




r.1917A>G 16S_rrsD r.1344T>C 
16S_rrsD 




r.2103T>C 16S_rrsD r.1356G>A 
16S_rrsD 
r.1455T>C 16S_rrsD r.1665G>A 16S_rrsD r.1665G>A 
16S_rrsD 
r.1281T>C 16S_rrsD r.2424A>T 16S_rrsD r.1506C>T 
16S_rrsD 




r.2442C>A 16S_rrsD r.1650A>G 
16S_rrsD 
r.1836C>T 16S_rrsD r.1819T>C 16S_rrsD r.1819T>C 
16S_rrsD 
r.1293T>C 23S r.78T>C 16S_rrsD r.1836C>T 
16S_rrsD 
r.1860T>C 16S_rrsD r.1860T>C 16S_rrsD r.1860T>C 
16S_rrsD 
r.1344T>C 23S r.137T>A 16S_rrsD r.1860T>C 
16S_rrsD 
r.1917A>G 16S_rrsD r.1917A>G 16S_rrsD r.1917A>G 
16S_rrsD 
r.1356G>A 23S r.142A>T 16S_rrsD r.1881C>G 
16S_rrsD 
r.1932C>G 16S_rrsD r.1920C>T 16S_rrsD r.1920C>T 
16S_rrsD 
r.1506C>T 23S r.264C>G 16S_rrsD r.1917A>G 
16S_rrsD 
r.2196C>A 16S_rrsD r.2424A>T 16S_rrsD r.2424A>T 
16S_rrsD 
r.1710G>A 23S r.284T>C 16S_rrsD r.1926A>G 16S_rrsD r.2424A>T 16S_rrsD r.2442C>A 16S_rrsD r.2442C>A 
16S_rrsD 
r.1740C>T 23S r.285G>A 16S_rrsD r.2298T>C 
16S_rrsD 
r.2442C>A 23S r.451T>C   
16S_rrsD 
r.1836C>T 23S r.348A>G 16S_rrsD r.2352C>T   23S r.562A>T   
16S_rrsD r.2424A>T 23S r.349T>C 16S_rrsD r.2355T>C   23S r.569T>C   
16S_rrsD 
r.2442C>A 23S r.353C>T 16S_rrsD r.2367A>G   23S r.577A>G   
23S r.138T>C 23S r.544C>G 23S r.149C>G   23S r.1165delC   
23S r.142A>T 23S r.547A>T 23S r.169T>C   23S r.1167_1168insT   
23S r.264C>G 23S r.548G>A 23S r.170G>A   23S r.1170T>G   
23S r.284T>C 23S r.549G>C 23S r.651T>C   23S r.1178C>T   
23S r.285G>A 23S r.550_551insT 23S r.762A>T   23S r.1567T>C   
23S r.348A>G 23S r.613A>T 23S r.769T>C   23S r.1888T>G   
23S r.349T>C 23S r.626A>C 23S r.777A>G       
23S r.353C>T 23S r.646T>C 23S r.1272A>G       
23S r.354A>G 23S r.766T>C 23S r.1285T>C       
23S r.504A>C 23S r.877A>T 23S r.1597T>C       
23S r.543G>C 23S r.884T>C 23S r.1599T>C       
23S r.547A>C 23S r.892A>G 23S r.1608G>A       
23S r.550C>G 23S r.1171G>A 23S r.1611C>G       
23S r.626A>C 23S r.1174T>G 23S r.1612C>A       
23S r.646T>C 23S r.1175delA 23S r.1613C>T       
23S r.766T>C 23S r.1178C>T 23S r.1615C>T       
23S r.877A>T 23S r.1211C>T 23S r.1616G>A       
23S r.884T>C 23S r.1219T>G 23S r.1618G>T       
23S r.892A>G 23S r.1220G>C 23S r.1619G>C       
23S r.1171G>A 23S r.1229C>G 23S r.1631A>G       
23S r.1174T>C 23S r.1230A>T 23S r.1750T>C       
23S r.1176T>G 23S r.1392A>G 23S r.1767T>C       
23S r.1178C>T 23S r.1405T>C 23S r.2088T>G       
23S r.1219T>G 23S r.1719T>C 23S r.2096A>G       
23S r.1220G>C 23S r.1730G>A 23S r.2678C>G       
23S r.1229C>G 23S r.1733C>G 23S r.2679C>A       
23S r.1230A>T 23S r.1734C>A 23S r.2683T>A       
23S r.1387A>G 23S r.1735C>T 23S r.2687G>T       
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23S r.1400T>C 23S r.1737C>T 23S r.2688G>C       
23S r.1523T>C 23S r.1738G>A         
23S r.1712T>C 23S r.1740G>T         
23S r.1723G>A 23S r.1741G>C         
23S r.1726C>G 23S r.1753A>G         
23S r.1727C>A 23S r.1872T>C         
23S r.1728C>T 23S r.1889T>C         
23S r.1730C>T 23S r.2210T>G         
23S r.1731G>A 23S r.2800C>G         
23S r.1733G>T 23S r.2801C>A         
23S r.1734G>C 23S r.2805T>A         
23S r.1746A>G 23S r.2809G>T         
23S r.1865T>C 23S r.2810G>C         
23S r.1882T>C           
23S r.2203T>G           
23S r.2793C>G           
23S r.2794C>A           
23S r.2798T>A           
23S r.2802G>T           
23S r.2803G>C           
23S r.56A>G           
23S r.78T>C           
23S r.113T>A           
23S r.114T>C           
23S r.137T>A           
23S r.142A>T           
23S r.146T>C           
23S r.147G>A           
23S r.210A>G           
23S r.211T>C           
23S r.215C>T           
23S r.216A>G           
 
DISCUSSION 
 The rRNA is the most commonly exploited 
RNA target for antibiotics. The bacterial ribosome 
comprises 30S and 50S ribonucleoprotein subunits, 
contains a number of binding sites for antibiotics and 
is an target for novel antibacterial agents (Howard et 
al., 1996). Bacterial ribosomes have two 
ribonucleoprotein subunits. The bacterial rRNA 
includes 5S, 16S and 23S rRNA, the smallest (5S 
rRNA) being an approximately 120 nt RNA. The 
smaller 30S subunit contains a single approximately 
1500 nt RNA (16S rRNA) and about 20 different 
proteins while the larger 50S subunit contains an 
approximately 2900 nt RNA (23S rRNA) and about 
30 different proteins (Moore, 2001). 
Aminoglycosides are a group of well-known 
antibiotics that have been used successfully for more 
than half a century. Streptomycin and gentamycin 
are typical antibiotics which function by binding to 
specific sites on bacterial rRNA and affecting the 
fidelity of protein synthesis. The rRNA aminoacyl-
tRNA site (rRNA A-site) is a major target for 
aminoglycosides which selectively kills bacterial 
cells. Binding of drug to the 16S subunit near the A-
site of the 30S subunit leads to a decrease in 
translational accuracy and inhibition of the 
translocation of the ribosome (Thomas, 
Hergenrother, 2008). 
 There are three main mechanisms for 
microorganisms to acquire antibiotic resistance such 
as (i) enzymatic inactivation or modification of 
antibiotics (e.g. β-lactamases inactivate penicillin) 
(Li, Nikaido, 2009); (ii) acquisition of mutations in 
target sites of the antibiotics; and (iii) decreasing the 
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net drug concentration in the cell by reducing drug 
permeability via cell wall or by increasing the 
activity of efflux pumps (e.g. tetracycline resistance) 
(Bassetti et al., 2017). Among these, acquisition of 
mutations in target sites of the antibiotics is often 
observed for ribosome targeting drugs such as 
streptomycin, gentamycin; the former three are 
known to target the 30 S subunit that contains the 
16 S rRNA as its main component, whereas the 
others are known to attack the 50 S subunit that 
contains the 23 S rRNA as its main component 
(Wilson, 2006). There are a large number of 
antibiotics that target the ribosome. This is because 
ribosomes play a crucial role in protein biosynthesis, 
translating messenger RNA-encoded genetic 
information into proteins, which consists of 
sequential multistep reactions such as initiation, 
elongation, termination, and recycling. There are 
different kinds of inhibitors targeting each step of the 
translation process (Lambert, 2012; Wilson, 2006; 
Wilson, 2014). As the ribosome is RNA-rich, and 
functionally critical sites exist mainly on RNAs (the 
decoding center in 16S rRNA and peptidyl 
transferase center in 23 S rRNA), many antibiotic 
target sites exist on rRNAs, as do several resistant 
point mutations (Hong et al., 2014; Noller, Yassin et 
al., 2005). 
 Many antibiotics inhibit the growth of bacteria 
by targeting protein biosynthesis. Streptomycin has 
been shown to interact directly with the small 
ribosomal subunit. The ribosome accuracy center is a 
highly conserved component of the translational 
apparatus, comprising an rRNA domain and several 
polypeptides of the small subunit. Mutations within 
rRNA genes have been found to confer drug 
resistance; for some of these mutations experimental 
proof for a cause-effect relationship has been 
provided (Andersson, Hughes, 2011; Cocozaki et al., 
2016; Smith et al., 2013; Springer et al., 2001). 
 We have provided a comprehensive summary 
of the point mutations in 16S rRNA and 23S rRNA 
genes expression across the multidrug-resistant 
Salmonella. The mRNA-seq of Salmonella isolates 
showed the collective expression of 193 point 
mutations genes conferring resistance to 
gentamycin and streptomycin. The presence of 
these genes could contribute to the pathogenicity 
of these Salmonella isolates and also indicates the 
potential for these isolates to resist various 
antibiotics. In this study, point mutations detected 
in Sal 4 and Sal 11 exhibited 100% concordance, 
with all isolates displaying phenotypic resistant to 
gentamycin and streptomycin and all containing 
point mutations typically associated with resistance 
to these antimicrobials (Table 1 and Table 2). 
Likewise, all of six streptomycin resistant strains 
carried point mutations. Despite the concordance 
between genotypic and phenotypic in Sal 4 and Sal 
11, there were some examples of disagreement. 
Most notably, there were four isolates (Sal 6, Sal 7, 
Sal 8, and Sal 12) that possessed point mutation 
genes (Table 2) but were not resistant to 
gentamycin (Table 1). A blast search released that 
these novel point mutation has not been reported 
previously in any organism. This result suggested 
that these point mutations are associated with 
resistance to streptomycin, and mutations expression 
in Sal 4 and Sal 11 are involved with gentamycin 
and streptomycin resistance in our isolates. Further 
studies are necessary in order to conclude association 
between these point mutations and gentamycin and 
streptomycin resistant in six isolates. 
CONCLUSION 
 Antibiotic resistance is a serious problem, more 
and more pathogenic bacterial are developing 
immunity to widely used antibiotics, rendering them 
useless. Tremendous effort is being made to identify 
the mechanisms and mutations that lead to bacterial 
resistance to antibiotics. Understanding this can help 
ensure we can effectively treat multidrug Salmonella 
resistant infections. Our results suggest that there are 
many unfound and uncharacterized antibiotic 
resistance point mutations in rRNA genes. These 
mutations might contribute to streptomycin resistant 
in Salmonella serovars. This result is only a 
prediction, further validation is required. 
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PHÁT HIỆN ĐỘT BIẾN GEN 16S rRNA VÀ 23S rRNA TRONG CÁC CHỦNG 
SALMONELLA ĐA KHÁNG THUỐC ĐƯỢC PHÂN LẬP TỪ CÁC NGUỒN KHÁC NHAU 
BẰNG PHƯƠNG PHÁP GIẢI TRÌNH TỰ RNA-SEQ 
 
Nguyễn Thanh Việt2,3, Võ Thị Bích Thủy1,3 
1Viện Nghiên cứu hệ gen, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 
2Viện Y Dược học Quân sự, Học viện Quân y 
3Học viện Khoa học và Công nghệ, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 
TÓM TẮT 
 Sự gia tăng của vi khuẩn kháng thuốc đang xảy ra trên toàn thế giới. Kháng kháng sinh là một vấn đề 
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nghiêm trọng đối với con người, vì các vi sinh vật gây bệnh có khả năng kháng thuốc sẽ làm mất tác dụng của 
kháng sinh. Cơ chế kháng thuốc ở vi khuẩn bao gồm các kênh bơm thải thuốc, cải biến và làm thoái biến thuốc, 
đột biến, thay đổi đích tác động của thuốc. Tuy nhiên, hiểu biết của chúng ta về cách vi khuẩn kháng kháng 
sinh vẫn còn rời rạc, đặc biệt là đối với các thuốc có đích tác động là ribosome. Salmonella là một nguyên nhân 
hàng đầu gây ô nhiễm thực phẩm trên thế giới. Số lượng vi khuẩn kháng kháng sinh này phân lập được ở người 
đang tăng lên, cho thấy sự lây lan của các loài vi khuẩn kháng kháng sinh là mối đe dọa lớn đối với sức khỏe 
cộng đồng. Salmonella thường có mặt trong một lượng lớn các loài động vật, trong thức ăn, và môi trường, 
nhưng kiến thức của chúng ta về cách Salmonella kháng thuốc vẫn còn chưa rõ ràng. Do đó, mục đích của 
nghiên cứu này là hỗ trợ trong việc nghiên cứu các cơ chế mới giúp vi khuẩn các kháng kháng sinh có đích tác 
động là ribosome. Chúng tôi sàng lọc biểu hiện đột biến của các gen 16S rRNA và 23S rRNA ở các loài 
Salmonella đa kháng kháng sinh phân lập được từ thịt bán lẻ ở khu vực Hà Nội, Việt Nam. Kết quả đã xác định 
được 193 đột biến điểm (64 đột biến ở gen 16S rRNA và 129 đột biến ở gen 23S rRNA). Những đột biến này 
có thể có vai trò trong đề kháng kháng sinh streptomycin. Kết quả này cho thấy rằng còn nhiều đột biến kháng 
kháng sinh vẫn còn chưa được biết đến, ngay cả đối với các kháng sinh cổ điển. Nghiên cứu này chỉ là kết quả 
sơ bộ, việc đánh giá thực nghiệm cần được tiến hành trước khi được áp dụng ở Salmonella và các loài vi khuẩn 
khác. 
Từ khóa: Salmonella đa kháng thuốc, đột biến điểm, 16S rRNA, 23S rRNA, giải trình tự mRNA 
 
 
